Alpha Tau Medical (DRTS) Depreciation & Amortization (CF) (2021 - 2022)
Alpha Tau Medical (DRTS) posted quarterly Depreciation & Amortization (CF) of $244000.0 for Q2 2022, up 5.63% on a QoQ basis from $231000.0 in Q1 2022.
Alpha Tau Medical (DRTS) Depreciation & Amortization (CF) (2021 - 2022) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Depreciation & Amortization (CF) for 2 consecutive years, with $244000.0 the latest figure, recorded in Q2 2022.
- Quarterly Depreciation & Amortization (CF) changed N/A year-over-year to $244000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $244000.0 (up 5.63% YoY) and the FY2025 annual result came in at $1.2 million, up 11.8% from the prior year.
- Depreciation & Amortization (CF) grew to $244000.0 in Q2 2022 per DRTS's latest filing, from $231000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for DRTS reached as high as $244000.0 in Q2 2022 and fell as low as $164000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Mar 31, 2021 | 164,000.00 |